These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 21979906)
1. Factors influencing patients' acceptance and adherence to active surveillance. Penson DF J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):207-12. PubMed ID: 23271775 [TBL] [Abstract][Full Text] [Related]
2. Who makes the decision regarding the treatment of clinically localized prostate cancer--the patient or physician?: results from a population-based study. Song L; Chen RC; Bensen JT; Knafl GJ; Nielsen ME; Farnan L; Wallen EM; Mishel M; Pruthi RS; Mohler JL; Godley PA Cancer; 2013 Jan; 119(2):421-8. PubMed ID: 22786794 [TBL] [Abstract][Full Text] [Related]
3. Patient-physician communication about early stage prostate cancer: analysis of overall visit structure. Henry SG; Czarnecki D; Kahn VC; Chou WY; Fagerlin A; Ubel PA; Rovner DR; Alexander SC; Knight SJ; Holmes-Rovner M Health Expect; 2015 Oct; 18(5):1757-68. PubMed ID: 24372758 [TBL] [Abstract][Full Text] [Related]
4. Decision Making in Prostate Cancer. Nadamuni M; D'Amico AV; Donovan JL; Hamdy FC N Engl J Med; 2023 Oct; 389(14):1335-1338. PubMed ID: 37792620 [No Abstract] [Full Text] [Related]
5. Clinical decision making in prostate cancer care-evaluation of EAU-guidelines use and novel decision support software. Engesser C; Henkel M; Alargkof V; Fassbind S; Studer J; Engesser J; Walter M; Elyan A; Dugas S; Trotsenko P; Sutter S; Eckert C; Hofmann S; Stalder A; Seifert H; Cornford P; Stieltjes B; Wetterauer C Sci Rep; 2024 Aug; 14(1):19113. PubMed ID: 39155288 [TBL] [Abstract][Full Text] [Related]
6. Significant Survival Differences for Grade Group 4 and Grade Group 5 Prostate Cancer: Detailed Reporting of Pathohistology and Modern Diagnostic Algorithms Are Needed To Tailor Treatment. Heidenreich A Eur Urol Oncol; 2024 Apr; 7(2):211-212. PubMed ID: 38000933 [No Abstract] [Full Text] [Related]
7. New technology in prostate cancer and financial toxicity. Maganty A; Hollenbeck BK Urol Oncol; 2023 Sep; 41(9):376-379. PubMed ID: 37173237 [TBL] [Abstract][Full Text] [Related]
8. [Elderly prostate cancer patients: patient information and shared decision making]. Ernstmann N; Jaeger J; Kowalski C; Pfaff H; Weißbach L Urologe A; 2013 Jun; 52(6):847-52. PubMed ID: 23328778 [TBL] [Abstract][Full Text] [Related]
11. [Diagnosis prostate cancer: who makes the treatment decision and which treatment is selected? Opinion survey in a prostate cancer patient support group]. Schnell D; Fiebrandt H; Weissbach L Urologe A; 2012 Feb; 51(2):238-41. PubMed ID: 21979906 [TBL] [Abstract][Full Text] [Related]
12. The dilemma of prostate-specific antigen testing. Leach R; Thompson IM Arch Intern Med; 2012 Jun; 172(11):835-6. PubMed ID: 22905350 [No Abstract] [Full Text] [Related]
13. [Early detection in prostate cancer and shared decision making]. Junod AF Praxis (Bern 1994); 2005 Sep; 94(39):1525-9. PubMed ID: 16223112 [TBL] [Abstract][Full Text] [Related]
15. Decision-making Processes among Prostate Cancer Survivors with Rising PSA Levels: Results from a Qualitative Analysis. Shen MJ; Nelson CJ; Peters E; Slovin SF; Hall SJ; Hall M; Herrera PC; Leventhal EA; Leventhal H; Diefenbach MA Med Decis Making; 2015 May; 35(4):477-86. PubMed ID: 25385751 [TBL] [Abstract][Full Text] [Related]